Open Access Open Access  Restricted Access Subscription Access

Understanding the Mechanism of Action of Antitussive Drugs

Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


Coughing is a natural reflex that assists in clearing the airways of irritants and mucus. Opioid have been used as an effective antitussive compounds namely codeine and hydro condone are helpful in stopping coughing in a wide manner. By binding with mu Opioid receptors, opioid ms stop the release of neurotransmitters particularly participated I'm the cough reflex and decrease the urge to cough. Dextro methorphin ( DXM) is a non_ Opioid derivative that participates in the over the counter cough medications. If performs centrally by blocking N_ methyl_D_ asparate (NMDA) receptors and stopping the transmission of signals in the cough centers. Sodium benzoate and benzonatate are examples of antitussives that act in a peripheral manner. Benzonatate performs by anesthetizing the stretch receptors particularly in the respiratory passages and decrease the sensitivity of the cough reflex. Expectorants namely guaifenesin play major role particularly I'm cough management by thinning mucus and enhancing it's removal. Gaifenesin enhances the volume and decreases the viscosity of respiratory tract secretions and makes cough more productive and less frequent. Cannbinoids namely cannabidiol (CBD) shows promise particularly in pre-clinical studies for their antitussive effects. Anti histamines namely dephenhydramine consist of anti tudsive properties. Drugs such as cromolyn sodium and nedocromil show their action peripheral ly by stabilizing mast cells and inhibiting the release of inflammatory mediators. Finally, it is concluded that antitussive drugs encompass a diverse array of compounds that target different aspects of the cough reflex.


Full Text:

PDF

References


Taylor CP, Traynelis SF, Siffert J, Pope LE, Matsumoto RR. Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use. Pharmacol Ther. 2016 Aug;164:170-82. [PubMed]

Pioro EP. Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect. Neurol Ther. 2014 Jun;3(1):15-28. [PMC free article] [PubMed]

Patatanian E, Casselman J. Dextromethorphan/quinidine for the treatment of pseudobulbar affect. Consult Pharm. 2014 Apr;29(4):264-9. [PubMed]

Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacol Ther. 2016 Mar;159:1-22. [PubMed]

Corado CR, McKemie DS, Knych HK. Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration. Drug Test Anal. 2017 Jun;9(6):880-887. [PubMed]

Werling LL, Lauterbach EC, Calef U. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Neurologist. 2007 Sep;13(5):272-93. [PubMed]

Wadelius M, Darj E, Frenne G, Rane A. Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther. 1997 Oct;62(4):400-7. [PubMed]

Tracy TS, Venkataramanan R, Glover DD, Caritis SN., National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Am J Obstet Gynecol. 2005 Feb;192(2):633-9. [PubMed]

Drugs and Lactation Database (LactMed®) [Internet]. National Institute of Child Health and Human Development; Bethesda (MD): Jan 16, 2023. Dextromethorphan. [PubMed]

Lauterbach EC. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan. Med Hypotheses. 2012 Jun;78(6):693-702. [PubMed]


Refbacks

  • There are currently no refbacks.